Your browser is no longer supported. Please, upgrade your browser.
EVFM Evofem Biosciences, Inc. monthly Stock Chart
EVFM [NASD]
Evofem Biosciences, Inc.
Index- P/E- EPS (ttm)-1.93 Insider Own1.40% Shs Outstand81.21M Perf Week-1.72%
Market Cap186.15M Forward P/E- EPS next Y-1.11 Insider Trans-93.92% Shs Float79.95M Perf Month-3.78%
Income-114.40M PEG- EPS next Q-0.33 Inst Own45.00% Short Float9.31% Perf Quarter-26.84%
Sales0.30M P/S620.51 EPS this Y65.40% Inst Trans-12.80% Short Ratio1.89 Perf Half Y-54.74%
Book/sh0.50 P/B4.58 EPS next Y42.70% ROA-157.10% Target Price- Perf Year-62.40%
Cash/sh1.07 P/C2.14 EPS next 5Y- ROE-365.00% 52W Range1.91 - 7.50 Perf YTD-62.88%
Dividend- P/FCF- EPS past 5Y42.70% ROI- 52W High-69.47% Beta0.32
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin21.90% 52W Low19.90% ATR0.15
Employees53 Current Ratio1.60 Sales Q/Q- Oper. Margin- RSI (14)47.17 Volatility5.35% 6.44%
OptionableYes Debt/Eq1.20 EPS Q/Q-23.40% Profit Margin- Rel Volume0.55 Prev Close2.26
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout- Avg Volume3.94M Price2.29
Recom2.00 SMA20-1.86% SMA50-7.08% SMA200-38.27% Volume2,187,094 Change1.33%
Oct-02-20Initiated Stifel Buy $5
Aug-20-20Initiated Morgan Stanley Equal-Weight $3
Jun-08-20Initiated Piper Sandler Overweight $11
Oct-16-19Resumed Cantor Fitzgerald Overweight $9
Nov-20-20 08:30AM  
Nov-12-20 08:30AM  
Nov-09-20 11:00PM  
04:01PM  
03:15PM  
Oct-27-20 08:00AM  
Oct-26-20 09:00AM  
Oct-20-20 08:00AM  
Oct-08-20 10:15AM  
Oct-07-20 08:00AM  
Sep-16-20 12:13PM  
Sep-14-20 09:42AM  
09:00AM  
Sep-11-20 12:02PM  
10:27AM  
Sep-07-20 11:57AM  
Aug-31-20 09:00AM  
Aug-21-20 06:00PM  
Aug-20-20 09:51AM  
Aug-11-20 08:53AM  
Aug-04-20 09:31PM  
08:00AM  
Aug-03-20 08:30AM  
Jul-23-20 08:30AM  
Jul-21-20 03:55AM  
03:55AM  
Jul-15-20 08:30AM  
Jul-01-20 08:01AM  
Jun-29-20 09:33AM  
Jun-26-20 08:44AM  
Jun-12-20 08:08AM  
Jun-03-20 12:31PM  
Jun-02-20 11:03PM  
04:01PM  
May-31-20 05:15PM  
May-28-20 06:30AM  
May-27-20 10:56AM  
08:55AM  
May-26-20 10:32AM  
09:52AM  
09:00AM  
08:42AM  
May-22-20 04:37PM  
04:05PM  
01:09PM  
01:07PM  
01:07PM  
May-21-20 04:05PM  
May-18-20 04:05PM  
May-13-20 08:00AM  
May-08-20 09:00AM  
May-07-20 07:30AM  
May-06-20 08:00AM  
May-01-20 05:21PM  
Apr-28-20 08:00AM  
Apr-24-20 08:30AM  
Apr-19-20 07:02AM  
Apr-10-20 04:05PM  
Mar-30-20 05:14PM  
Mar-27-20 08:30AM  
Mar-25-20 05:00PM  
Mar-24-20 04:00PM  
Mar-19-20 08:15AM  
Mar-12-20 09:00AM  
08:00AM  
Mar-09-20 11:53AM  
Feb-26-20 08:30AM  
Feb-16-20 08:25AM  
Dec-22-19 05:32PM  
Dec-18-19 07:30AM  
Dec-03-19 09:00AM  
07:59AM  
Dec-02-19 08:07AM  
07:18AM  
06:50AM  
Nov-24-19 04:19PM  
Nov-14-19 08:00AM  
Nov-13-19 04:05PM  
Nov-08-19 08:30PM  
Nov-07-19 11:26AM  
Nov-06-19 04:05PM  
Oct-24-19 09:00AM  
Sep-25-19 09:00AM  
Sep-11-19 01:31PM  
Aug-26-19 06:00AM  
Aug-22-19 09:30AM  
Aug-08-19 11:23AM  
10:17AM  
Aug-05-19 04:10PM  
04:05PM  
Jul-30-19 09:00AM  
Jul-01-19 09:31AM  
Jun-10-19 04:01PM  
May-30-19 11:02AM  
May-14-19 09:00AM  
May-10-19 10:51AM  
May-09-19 07:24PM  
May-07-19 06:00AM  
Apr-30-19 09:00AM  
Apr-23-19 08:11AM  
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
File Justin J.Chief Financial OfficerNov 17Buy2.177,76016,839258,168Nov 18 05:22 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryNov 17Buy2.209,09019,998143,542Nov 18 05:14 PM
Barrans RussellChief Commercial OfficerSep 11Buy2.083,0006,240279,052Sep 11 05:20 PM
Barrans RussellChief Commercial OfficerSep 10Buy2.711,0002,710276,052Sep 11 05:20 PM
PELLETIER SAUNDRA LChief Executive OfficerSep 08Sale3.26122,500399,350360,888Sep 10 08:04 PM
Rarick Lisa DaleDirectorJun 17Buy2.995,25015,6985,250Jun 18 04:29 PM
Hall William WalmsleyDirectorJun 15Buy2.855,00014,2505,000Jun 17 08:38 PM
File Justin J.Chief Financial OfficerJun 12Buy3.148,50026,690250,408Jun 15 04:16 PM
Kamdar Kim P.DirectorJun 12Buy2.945,00014,7009,287Jun 16 04:35 PM
Invesco Ltd.10% OwnerJun 05Buy3.50857,1433,000,00113,226,532Jun 09 06:49 AM
Link Fund Solutions Ltd10% OwnerJun 04Sale0.239,138,5042,101,8560Jul 17 11:11 AM
ACACIA RESEARCH CORP10% OwnerJun 04Sale3.219,138,50429,325,4591,000Jun 09 09:08 PM
Invesco Ltd.10% OwnerMay 26Sale5.7973,879427,77212,369,389Jun 09 06:49 AM
Invesco Ltd.10% OwnerMay 15Sale5.043,21116,18312,443,268Jun 09 06:49 AM
Culwell KellyChief Medical OfficerMay 01Sale4.751,0004,750194,226May 01 08:12 PM
Culwell KellyChief Medical OfficerApr 30Sale4.661,0004,660195,226May 01 08:12 PM
Lynch Thomas GDirectorMar 31Option Exercise0.0037,5000325,000Apr 01 04:11 PM
Barrans RussellChief Commercial OfficerFeb 19Sale6.5014,95797,221332,240Feb 21 02:10 PM
Culwell KellyChief Medical OfficerFeb 19Sale7.001,0007,000196,226Feb 21 02:10 PM
Barrans RussellChief Commercial OfficerJan 16Sale6.501,57810,257196,298Jan 21 01:13 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 13Sale6.003,29519,770362,289Jan 15 04:22 PM
File Justin J.Chief Financial OfficerJan 13Sale6.001,6489,888177,251Jan 15 04:22 PM
File Justin J.Chief Financial OfficerJan 02Sale6.053,35220,280178,899Jan 06 03:07 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 02Sale6.056,70540,565365,584Jan 06 03:08 PM
Lynch Thomas GDirectorDec 31Option Exercise0.0037,5000287,500Dec 31 08:48 PM
Culwell KellyChief Medical OfficerDec 02Sale7.351,0007,35043,538Dec 04 05:34 PM
PELLETIER SAUNDRA LChief Executive OfficerDec 02Sale7.3020,000146,000372,289Dec 04 05:33 PM
File Justin J.Chief Financial OfficerDec 02Sale7.1610,00071,600182,251Dec 04 05:33 PM